Yuhan Corporation
Asia, Seoul-t'ukpyolsi, South Korea, Seoul'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
Description
Yuhan Co, Ltd. is a South Korean pharmaceutical and chemical company.
Investor Profile
Yuhan Corporation has backed more than 4 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in South Korea.
- Strong thematic focus on Health Care, Biotechnology, Information Technology.
- Led 1 rounds in the past year.
Stage Focus
- Seed (50%)
- Series C (25%)
- Post Ipo Equity (25%)
Country Focus
- South Korea (100%)
Industry Focus
- Health Care
- Biotechnology
- Information Technology
- Medical
- Artificial Intelligence (Ai)
- Medical Device
- Software
- Pharmaceutical
- Therapeutics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
